02/08/2021

EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics

EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
29/07/2021

EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’

26/07/2021

EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised

22/07/2021

Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites

20/07/2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

03/07/2021

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
03/05/2021

EuropaBio launches a new Biopharmaceutical Strategy Group

25/04/2021

EuropaBio invited industrial biotech SMEs to learn about EU Policy Priorities

Webinar Report.
Become a member